在老鼠中中枢神经系统和脑后神经系统中未结合的eletriptan和sumatriptan的区域分布:对潜在的中心作用的影响
Nana Svane1, Frida Bällgren2, Aghavni Ginosyan2
1Department of Pharmacy, CNS Drug Delivery and Barrier Modelling group (CNSBM), University of Copenhagen, Copenhagen, Denmark.
The journal of headache and pain
|October 31, 2024
概括
三药有效地治疗偏头痛,通过达到外周和中枢神经系统的受体. 尽管血脑屏障的透能力有限,但eletriptan和sumatriptan实现了显著的5-HT受体占用,这表明在偏头痛治疗中可能存在潜在的中心机制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 偏头痛治疗方法 偏头痛治疗方法
背景情况:
- 三类药物是5-HT1B/1D/1F受体激动剂,对偏头痛治疗至关重要,主要被认为是外围作用.
- 试剂在多大程度上穿越血脑屏障 (BBB) 参与中央5-HT受体仍然不完全理解.
- 这项研究调查了electriptan和sumatriptan在中枢神经系统 (CNS) 和周围神经系统 (PNS) 的分布.
研究的目的:
- 评估在中枢神经系统和脑后神经系统组织中埃莱特里普坦和苏马特里普坦的区域分布.
- 在临床相关度下预测5-HT1B/1D/1F受体的占用.
- 阐明三剂对中心与外围目标的潜在作用.
主要方法:
- 采用组合映射方法 (CMA) 来确定大鼠的未结合组织与血度比 (Kp, uu, ROI).
- 在稳定状态下,分析了Kp,uu,ROI在各种中枢神经系统区域 (例如,下丘脑,皮质,整个大脑) 和PNS区域 (三腺,坐骨神经) 中.
- 额外推算大鼠Kp,uu,ROI值,以估计人类的未结合度和受体占用率.
主要成果:
- 与BBB相比,证明了异质的三分布,与BBB相比,在三腺 (TG) 的血神经屏障中具有更高的未结合药物运输.
- 观察到BBB中对electriptan和sumatriptan的限制进入,在中枢神经系统内具有显著的区域间变异性.
- 预测在三角质中几乎完全的5-HT1B/1D/1F受体占用率,在整个大脑中占用率较低,尽管显著.
结论:
- 埃利特里普坦和苏马特里普坦达到足够的未结合度,在三角质和中枢神经系统中刺激5-HT受体,尽管BBB透程度有限.
- 这些发现表明,中央机制可能有助于三的抗偏头痛作用.
- 需要进一步研究以澄清中央受体刺激在治疗疗效和潜在副作用方面的作用.
相关概念视频
Neurochemical Transmission: Sites of Drug Action
3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.9K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.9K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
997
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
997
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
5.7K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
5.7K
Factors Affecting Drug Distribution: Organ Perfusion Rate
837
Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
Perfusion rate-limited distribution relies on the...
Perfusion rate-limited distribution relies on the...
837
Tissue-Drug Binding: Localization of Drugs and its Significance
602
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
602


![Autoradiographic Measurements of [14C]-Iodoantipyrine in Rat Brain Following Central Post-Stroke Pain](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F53947.jpg&w=3840&q=50)